News Focus
News Focus
Followers 38
Posts 1153
Boards Moderated 0
Alias Born 03/20/2013

Re: ilovetech post# 435771

Monday, 01/17/2022 4:52:30 PM

Monday, January 17, 2022 4:52:30 PM

Post# of 818078
ILT, as I have said in the past AMRN was ultimately a heart breaker, Luckly I took some off the table in the initial run up and made some $$$, but society will never benefit from what Vascepa can do for a person with cardiovascular disease. The company was cut off at the knees and has been left to struggle the rest of their existence. NWBO is a much different company with a much different product and its barriers to enter the market are much more complex than Vascepa, a generic company will not be able to just start producing DCVax. Thats the beauty of the NW Bio story and how LP and the team are building a fortress around what they are creating.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News